Scopolamine Sublingual Spray: An Alternative Route of Delivery for the Treatment of Motion Sickness

Author： Al-Ghananeem Abeer M. Malkawi Ahmad H. Crooks Peter A.

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.33, Iss.5, 2007-05, pp. : 577-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Scopolamine nasal spray in motion sickness: a randomised, controlled, and crossover study for the comparison of two scopolamine nasal sprays with oral dimenhydrinate and placebo

By Klocker N. Hanschke W. Toussaint S. Verse T.

European Journal of Pharmaceutical Sciences, Vol. 13, Iss. 2, 2001-05 ,pp. : 227-232

Elsevier

Access to resources Recommend Favorite

Transdermal Scopolamine for Prevention of Motion Sickness: Clinical Pharmacokinetics and Therapeutic Applications

By Nachum Zohar Shupak Avi Gordon Carlos R.

Clinical Pharmacokinetics, Vol. 45, Iss. 6, 2006-01 ,pp. : 543-566

Adis International

Access to resources Recommend Favorite

Prevention and Treatment of Motion Sickness in Children

By Gordon C.R.

CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 369-381

Adis International

Access to resources Recommend Favorite

Motion sickness in migraine sufferers

By Marcus Dawn A Furman Joseph M Balaban Carey D

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2691-2697

Informa Healthcare

Access to resources Recommend Favorite

Delivery of Peptides Via the Oral Route: Diabetes Treatment by Peptide-Loaded Nanoparticles

Current Pharmaceutical Design, Vol. 22, Iss. 9, 2016-03 ,pp. : 1161-1176

Bentham Science Publishers

Access to resources Recommend Favorite